Healthtech · Denmark · Est. 2019
By combining advanced metagenomics and AI-assisted data mining, we develop personalised, science-backed health solutions that address the challenges of tomorrow.
What we do
Three interlocking capabilities form the backbone of everything we build — from concept to market in under 18 months.
We study complex microbial communities across gut, oral, and vaginal microbiomes — going beyond data collection to understand deep interactions between microbiome and host.
Proprietary algorithms identify hidden patterns across large-scale metagenomic datasets, accelerating discovery and reducing time-to-market for precision health solutions.
We integrate biological data from multiple physiological levels to model health and disease holistically — enabling interventions tailored to each individual's unique biology.
Our vision
"Personalised, data-driven healthcare
should be the standard — not the exception."
We are committed to transforming the future of healthcare by inviting partners, investors, and visionaries to join us. Together, we make it real.
From a bold idea to a market-validated product — we move through four phases with speed, rigour, and our partners at every step.
We work closely with partners to explore new ideas and identify where our combined expertise makes the most impact.
We leverage our core technologies to build, refine, and mature the technology until it is robust and ready for market validation.
We demonstrate commercial viability. Successful projects may spin out as independent companies or be in-licensed by partners.
We build relationships that endure — giving partners access to our innovation pipeline and a competitive edge in health tech.
Our brands
Plant-based prebiotics supporting mental health, sleep, weight management, and immunity. Launched 2020. Customer lifetime value far exceeding acquisition costs.
↗Personalised gut microbiota profiling and tailored food recommendations. Built on data from over 5,000 clinical studies. Thousands of validated customers.
↗